---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-026431"
form_type: "8-K"
ticker: "IMMX"
cik: "0001873835"
company_name: "Immix Biopharma, Inc."
filed_at: "2026-05-29T21:10:15+00:00"
generated_at: "2026-05-29T21:15:06.554721+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Immix Biopharma shareholders elect directors and ratify Crowe LLP as auditor at 2026 annual meeting

## Summary
- All nine director nominees (including Ilya Rachman, Gabriel Morris, Jason Hsu) elected with over 35M votes each; broker non-votes ~6.4M.
- Ratification of Crowe LLP as independent auditor for FY 2026 passed: 42.3M For, 11.5K Against, 18.4K Abstentions.
- Meeting held May 22, 2026; results reported on May 29, 2026; overwhelming support for all proposals.

## SEC filing metadata
- accession: 0001493152-26-026431
- form_type: 8-K
- ticker: IMMX
- cik: 0001873835
- company_name: Immix Biopharma, Inc.
- filed_at: 2026-05-29T21:10:15+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873835/000149315226026431/0001493152-26-026431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873835/000149315226026431/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-026431
- JSON: https://secwatch.observer/filing/0001493152-26-026431.json
- Plain text: https://secwatch.observer/filing/0001493152-26-026431.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.